Immunosuppressive treatment for proliferative lupus nephritis-Reference-Cited by-同舟云学术

Immunosuppressive treatment for proliferative lupus nephritis

Published:2018-06-29 Issue:6 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tunnicliffe David J¹²,Palmer Suetonia C³,Henderson Lorna⁴,Masson Philip⁵,Craig Jonathan C¹⁶⁷,Tong Allison¹²,Singh-Grewal Davinder⁸,Flanc Robert S⁹,Roberts Matthew A¹⁰,Webster Angela C¹⁶¹¹,Strippoli Giovanni FM¹⁶¹²¹³¹⁴

Affiliation:

1. The University of Sydney; Sydney School of Public Health; Sydney NSW Australia 2006

2. The Children's Hospital at Westmead; Centre for Kidney Research; Westmead Australia

3. University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140

4. NHS Lothian; Renal Department; Royal Infirmary of Edinburgh Edinburgh UK EH16 4SA

5. Royal Free London NHS Foundation Trust; Department of Renal Medicine; London UK

6. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

7. Flinders University; College of Medicine and Public Health; Adelaide SA Australia 5001

8. The Sydney Children's Hospitals Network; Department Paediatric Rheumatology; The Children's Hospital at Westmead Cnr Hainsworth and Hawkesbury Roads Westmead NSW Australia 2145

9. Monash Medical Centre; Department of Nephrology; Clayton Rd Clayton VIC Australia 3168

10. Monash University; Eastern Health Clinical School; Box Hill VIC Australia 3128

11. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

12. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy

13. Diaverum; Medical Scientific Office; Lund Sweden

14. Diaverum Academy; Bari Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002922.pub4/epdf/full

Reference420 articles.

1. Comparison between corticosteroid and mycophenolate mofetil and corticosteroid and cyclophosphamide in the treatment of lupus nephritis [abstract no: FO031];Abedi;Nephrology Dialysis Transplantation,2007

2. Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.[Erratum appears in Arthritis Rheumatol. 2015 Feb;67(2):487 Note: Aranow, Cynthia [added]];ACCESS Trial Group;Arthritis & Rheumatology,2014

3. 24 hour protein: creatinine ration (24 PCR), not spot PCR (Spot PCR), should be used to monitor the treatment of severe lupus nephritis (LN): the experience of ACCESS [abstract no: FR-PO604];Shidham;Journal of the American Society of Nephrology,2016

4. Ability of spot urine protein/creatinine ratio (spot PCR) to correctly identify the proteinuria endpoints of complete remission (CR), partial remission (PR), and treatment failure (TF) as determined by 24 hour urine PCR (24 PCR): experience of abatacept and cyclophosphamide combination efficacy and safety study (ACCESS) [abstract no: TH-PO764];Shidham;Journal of the American Society of Nephrology,2015

5. Treatment of lupus nephritis with abatacept plus low-dose pulse cyclophosphamide followed by azathioprine (the Euro-Lupus regimen): twenty-four week data from a double-blind controlled trial [abstract no: 884];Wofsy;Arthritis & Rheumatology,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical recommendations on diagnostics and treatment of lupus nephritis (draft project);Nephrology and Dialysis;2024-08-13

2. KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Translated into Russian by E.V. Zakharova;Nephrology and Dialysis;2024-08-13

3. Efficacy and safety of telitacicept in patients with lupus nephritis;Experimental and Therapeutic Medicine;2024-07-23

4. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis;Renal Failure;2024-06-07

5. Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus;Current Rheumatology Reviews;2024-04-30